March 2020 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for March 2020. This roundup includes...
Doctors, Hospitals, Pharmacies Warned Not to Stockpile Meds
Professional societies issue stern warning not to inappropriately prescribe meds for COVID-19
Methylation Analysis of cfDNA IDs >50 Cancer Types
Sensitivity increased with increasing stage from 39 percent in stage I to 92 percent in stage IV
U.S. Army Opens Field Hospital in New York City
Field hospital in Manhattan meant to handle non-COVID-19 patients to free up space in city hospitals
ACC: Statins Cut Heart Failure Risk in Early Breast Cancer Treatment
Risk for heart failure hospital visit declined with statins for women receiving anthracyclines, trastuzumab
Reduction Noted in Transfusion Burden With Luspatercept
Reduction seen with luspatercept versus placebo for patients with transfusion-dependent β-thalassemia
Prospective, Randomized Studies of AI Lacking in Medical Imaging
Many studies claiming artificial intelligence as good as humans are of poor quality, with high risk for bias
Acute Kidney Injury Seems to Promote Renal Cell Carcinoma
AKI promotes the development of papillary renal cell carcinoma from single progenitors
Increased Risk for SARS-CoV-2 Seen in Cancer Patients in Wuhan
Of the 12 patients with COVID-19, six developed severe acute respiratory syndrome; three died
Workers at Risk for COVID-19 Exposure Can Access Online Training
The National Institute of Environmental Health Sciences launched virtual training website to protect workers
